Home > Compound List > Product Information
5,6-Diamino-1,3-dimethyluracil hydrate_Molecular_structure_CAS_5440-00-6)
Click picture or here to close

5,6-Diamino-1,3-dimethyluracil hydrate

Catalog No. D15901 Name Sigma Aldrich
CAS Number 5440-00-6 Website http://www.sigmaaldrich.com
M. F. C6H12N4O3 Telephone 1-800-521-8956
M. W. 188.18448 Fax
Purity Email
Storage Chembase ID: 121868

SYNONYMS

Title
5,6-二氨基-1,3-二甲基脲嘧啶 水合物
IUPAC name
5,6-diamino-1,3-dimethyl-1,2,3,4-tetrahydropyrimidine-2,4-dione hydrate
IUPAC Traditional name
5,6-diamino-1,3-dimethylpyrimidine-2,4-dione hydrate
Synonyms
NSC 15493
5,6-二氨基-1,3-二甲基-2,4(1H,3H)-嘧啶二酮
4,5-Diamino-1,3-dimethyl-2,6-dioxotetrahydropyrimidine
5,6-Diamino-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione

DATABASE IDS

EC Number 226-621-9
Beilstein Number 157451
CAS Number 5440-00-6
PubChem SID 24893488
MDL Number MFCD00149431

PROPERTIES

Empirical Formula (Hill Notation) C6H10N4O2 · xH2O
Grade technical grade
Melting Point 210-214 °C (dec.)(lit.)
MSDS Link Download
Personal Protective Equipment Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter
German water hazard class 3

DETAILS

Description (English)
Packaging
25 g in poly bottle
5 g in glass bottle
Application
Reactant involved in the synthesis of biologically active molecules including:
• 1H-Imidazol-1-yl substituted 8-phenylxanthines for use as adenosine receptor ligands1
• Pyrimidinyl purinediones via cyclocondensation2
• Theophylline derivatives as adenosine receptor antagonists3
• Pteridine analogs for use as monoamine oxidase B and nitric oxide synthase inhibitors4
• Fused tricyclic xanthines5
• Cadmium uraciliminoethylpyridine complexes for use as antiproliferatives against C6 glioma cells6
Description (简体中文)
包装
25 g in poly bottle
5 g in glass bottle
Application
Reactant involved in the synthesis of biologically active molecules including:
• 1H-Imidazol-1-yl substituted 8-phenylxanthines for use as adenosine receptor ligands1
• Pyrimidinyl purinediones via cyclocondensation2
• Theophylline derivatives as adenosine receptor antagonists3
• Pteridine analogs for use as monoamine oxidase B and nitric oxide synthase inhibitors4
• Fused tricyclic xanthines5
• Cadmium uraciliminoethylpyridine complexes for use as antiproliferatives against C6 glioma cells6

REFERENCES